• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解剖学与乳腺癌分期:它仍然相关吗?

Anatomy and Breast Cancer Staging: Is It Still Relevant?

作者信息

Plichta Jennifer K, Campbell Brittany M, Mittendorf Elizabeth A, Hwang E Shelley

机构信息

Department of Surgery, Duke University Medical Center, DUMC 3513, Durham, NC 27710, USA.

Department of Breast Surgical Oncology, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

出版信息

Surg Oncol Clin N Am. 2018 Jan;27(1):51-67. doi: 10.1016/j.soc.2017.07.010.

DOI:10.1016/j.soc.2017.07.010
PMID:29132565
Abstract

Breast cancer staging concisely summarizes disease status, creating a framework for assessing and relaying prognostic information. The fundamental concepts and components of breast cancer staging are reviewed. The AJCC Cancer Staging Manual, which includes traditional anatomic factors, now includes additional tumor characteristics: tumor grade, estrogen receptor status, progesterone receptor status, human epidermal growth factor receptor 2 status, and (when available) multigene panel testing from the primary tumor. With these updates, staging provides the most reliable system for accurately predicting patient outcome. When the AJCC 8th edition guidelines are adopted, they will more closely reflect tumor biology.

摘要

乳腺癌分期简明扼要地总结了疾病状态,为评估和传递预后信息创建了一个框架。本文回顾了乳腺癌分期的基本概念和组成部分。美国癌症联合委员会(AJCC)癌症分期手册,其中包括传统的解剖学因素,现在还纳入了其他肿瘤特征:肿瘤分级、雌激素受体状态、孕激素受体状态、人表皮生长因子受体2状态,以及(如有可用数据)来自原发肿瘤的多基因检测。通过这些更新,分期提供了最可靠的系统来准确预测患者的预后。当采用AJCC第8版指南时,它们将更紧密地反映肿瘤生物学特性。

相似文献

1
Anatomy and Breast Cancer Staging: Is It Still Relevant?解剖学与乳腺癌分期:它仍然相关吗?
Surg Oncol Clin N Am. 2018 Jan;27(1):51-67. doi: 10.1016/j.soc.2017.07.010.
2
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.乳腺癌——美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2017 Jul 8;67(4):290-303. doi: 10.3322/caac.21393. Epub 2017 Mar 14.
3
[The 8th edition of the American Joint Committee on Cancer staging system provide improved prognostic accuracy in T1-2N1M0 postmastectomy breast cancer patients].美国癌症联合委员会第8版分期系统提高了T1-2N1M0乳房切除术后乳腺癌患者的预后准确性。
Zhonghua Zhong Liu Za Zhi. 2019 Aug 23;41(8):615-623. doi: 10.3760/cma.j.issn.0253-3766.2019.08.011.
4
Breast Cancer Staging: Updates in the , 8th Edition, and Current Challenges for Radiologists, From the Special Series on Cancer Staging.乳腺癌分期:第 8 版 AJCC 分期的更新及放射科医师面临的挑战,选自癌症分期特别专题系列。
AJR Am J Roentgenol. 2021 Aug;217(2):278-290. doi: 10.2214/AJR.20.25223. Epub 2021 Feb 17.
5
The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.美国癌症联合委员会(AJCC)第8版分期系统在HER2富集亚型乳腺癌中的预后价值:一项回顾性分析
Anticancer Res. 2017 Aug;37(8):4615-4621. doi: 10.21873/anticanres.11862.
6
Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System: Review of the Supporting Evidence.将生物学因素纳入美国癌症联合委员会乳腺癌分期系统:支持证据的回顾。
Surg Clin North Am. 2018 Aug;98(4):687-702. doi: 10.1016/j.suc.2018.03.005. Epub 2018 May 21.
7
American Joint Committee on Cancer's Staging System for Breast Cancer, Eighth Edition: What the Radiologist Needs to Know.美国癌症联合委员会第八版乳腺癌分期系统:放射科医生需要知道的内容。
Radiographics. 2018 Nov-Dec;38(7):1921-1933. doi: 10.1148/rg.2018180056. Epub 2018 Sep 28.
8
The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual.乳腺癌中的联合 pN 分期和乳腺癌亚型:可更好地区分预后的指标,可用于完善第 8 版 AJCC 分期手册。
Breast Cancer. 2018 May;25(3):315-324. doi: 10.1007/s12282-018-0833-0. Epub 2018 Jan 20.
9
The assessment of 8th edition AJCC prognostic staging system and a simplified staging system for breast cancer: The analytic results from the SEER database.第8版美国癌症联合委员会(AJCC)乳腺癌预后分期系统及简化分期系统的评估:来自监测、流行病学和最终结果(SEER)数据库的分析结果
Breast J. 2019 Sep;25(5):838-847. doi: 10.1111/tbj.13347. Epub 2019 Jun 13.
10
Validation of the pathological prognostic staging system proposed in the revised eighth edition of the AJCC staging manual in different molecular subtypes of breast cancer.验证修订版第八版 AJCC 分期手册中不同乳腺癌分子亚型的病理预后分期系统。
Virchows Arch. 2019 Feb;474(2):193-200. doi: 10.1007/s00428-018-2495-x. Epub 2018 Nov 24.

引用本文的文献

1
Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer.III期与初发性IV期乳腺癌患者生存结局的比较。
Cancer. 2025 May 15;131(10):e35891. doi: 10.1002/cncr.35891.
2
Assessment of Treatment Sequence in Patients With Stage III Breast Cancer.评估 III 期乳腺癌患者的治疗顺序。
J Surg Res. 2024 Oct;302:347-358. doi: 10.1016/j.jss.2024.07.071. Epub 2024 Aug 14.
3
Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With Breast Cancer?解剖学与生物学:哪些因素指导老年乳腺癌患者的化疗决策?
J Surg Res. 2024 Apr;296:654-664. doi: 10.1016/j.jss.2024.01.037. Epub 2024 Feb 14.
4
The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer.美国癌症联合委员会(AJCC)第8版病理预后分期对N2/N3期乳腺癌乳房切除术后放疗获益的预测作用
Breast Cancer (Dove Med Press). 2022 May 13;14:133-144. doi: 10.2147/BCTT.S362355. eCollection 2022.
5
Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer.AJCC 预后分期对激素受体阳性和 HER2 阳性乳腺癌患者预后和术后放疗决策的影响。
BJS Open. 2022 Mar 8;6(2). doi: 10.1093/bjsopen/zrac025.
6
American Joint Committee on Cancer's Staging System for Breast Cancer, Eighth Edition: Summary for Clinicians.美国癌症联合委员会乳腺癌分期系统第八版:临床医生总结
Eur J Breast Health. 2021 Jun 24;17(3):234-238. doi: 10.4274/ejbh.galenos.2021.2021-4-3. eCollection 2021 Jul.
7
Validation of the 8 edition of the American Joint Committee on Cancer Pathological Prognostic Staging for young breast cancer patients.验证第 8 版美国癌症联合委员会病理预后分期系统在年轻乳腺癌患者中的应用。
Aging (Albany NY). 2020 Apr 22;12(8):7549-7560. doi: 10.18632/aging.103111.
8
Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?腋窝淋巴结清扫术在淋巴结阳性乳腺癌中的应用:十个淋巴结足够吗?何时才足够?
Breast Cancer Res Treat. 2020 Feb;179(3):661-670. doi: 10.1007/s10549-019-05500-9. Epub 2019 Nov 18.
9
Clinical and pathological stage discordance among 433,514 breast cancer patients.433514 例乳腺癌患者的临床与病理分期差异。
Am J Surg. 2019 Oct;218(4):669-676. doi: 10.1016/j.amjsurg.2019.07.016. Epub 2019 Jul 18.
10
Impact of Micrometastatic Axillary Nodes on Survival of Breast Cancer Patients with Tumors ≤2 cm.微转移腋窝淋巴结对肿瘤≤2厘米的乳腺癌患者生存的影响。
World J Surg. 2018 Dec;42(12):3969-3978. doi: 10.1007/s00268-018-4725-4.